Takako Otera

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults

R. Morishita, H. Rakugi, H. Nakagami, 2022, Vaccines.

Preclinical study of a DNA vaccine targeting SARS-CoV-2

R. Morishita, H. Rakugi, Y. Matsuura, 2020, bioRxiv.

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant

R. Morishita, Masahiro Yamamoto, H. Rakugi, 2022, Scientific Reports.

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction

R. Morishita, H. Rakugi, M. Shimamura, 2023, Scientific reports.

Preclinical study of a DNA vaccine targeting SARS-CoV-2

R. Morishita, M. Shimamura, H. Nakagami, 2022, Current Research in Translational Medicine.